Aldeyra Therapeutics principal financial officer Michael Alfieri reports $6,500 common share acquisition
ALDX•Michael Alfieri purchased 10,000 Aldeyra Therapeutics common shares at $0.65 each, increasing his directly held stake to 17,500 shares.
1. Share purchase
Aldeyra Therapeutics Principal Financial Officer Michael Alfieri purchased 10,000 common shares at $0.65 each. The purchase increased his directly held stake to 17,500 shares.
